Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9828408 HCV polymerase inhibitors

Patent 9828408 was granted and assigned to Medivir on November, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Medivir

Current Assignee

Medivir

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9828408

Date of Patent

November 28, 2017

Patent Application Number

15360360

Date Filed

November 23, 2016

Patent Citations Received

‌

US Patent 12012431 Methods of preparing 1′-cyano nucleosides

‌

US Patent 11939347 1′-cyano nucleoside analogs and uses thereof

‌

US Patent 11975017 Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections

‌

US Patent 11975012 Remdesivir treatment methods

‌

US Patent 11701372 Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs

‌

US Patent 11751568 Picolinamide compounds with fungicidal activity

‌

US Patent 11771085 Synergistic mixtures for fungal control in cereals

‌

US Patent 11780844 Compounds and methods for treatment of viral infections

...

Patent Primary Examiner

‌

Traviss C Mcintosh, III

Patent abstract

The invention provides compounds of the formula:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9828408 HCV polymerase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API